Synthesis of 2-Substituted 2H-Azepines
Cl2) δ 1.09 (9H, s), 3.03 (1H, ddd, J ) 18.9, 3.7, 2.7 Hz), 3.09
(1H, ddd, J ) 18.9, 4.0, 2.4 Hz), 3.48 (3H, s), 3.61 (3H, s), 4.86
(1H, ddd, J ) 4.0, 3.7, 2.1 Hz), 5.75 (1H, ddd, J ) 3.1, 2.7, 2.4
Hz), 5.86 (1H, dd, J ) 3.1, 2.1 Hz); 13C NMR (125 MHz, CD2-
Cl2) δ 28.2 (q), 37.0 (s), 40.3 (t), 43.1 (d), 52.5 (q), 54.6 (q), 84.8
(d), 133.4 (d), 147.9 (s), 162.1 (s).
Reaction of 1b with 0.5 equiv of NBS. NBS (100 mg,
0.56 mmol) was dropped into a solution of 2-methoxy-3H-
azepine 1b (200 mg, 1.12 mmol) in CH2Cl2 (10 mL) stirred
under a nitrogen atmosphere at room temperature then the
solution was stirred for 5 h at room temperature before
treatment with aq K2CO3. The organic phase was separated
and dried over MgSO4. Separation of the reaction mixture by
MPLC on Woelm 32-63 silica gel eluted with 1:4 v/v AcOEt-
hexane at 0 °C gave unreacted 1b (50 mg, 0.28 mmol) and 13
(120 mg, 63%, 84% yield based on converted 1b). Recrystalli-
zation of 13 from AcOEt and hexane gave colorless plates.
(d), 127.9 (d), 139.7 (d), 146.6 (s), 152.1 (s), 159.6 (s), 171.3 (s).
IR (KBr) νmax 1671, 1636, 1466, 1448, 1267, 1201 cm-1; UV-
vis (EtOH) λmax 265 nm (log ꢀ 3.10); MS (FAB) m/z 453 (M +
H)+; HRMS (FAB) m/z found 453.1757, calcd for C22H34BrN2O3
(M + 1)+ 453.1752.
Elimination of HBr from 16. A solution of 16 (270 mg,
0.60 mmol) in 5 mL of 1.0 M methanolic tetrabutylammonium
hydroxide was stirred at room temperature for 2.5 days
(reaction progress monitored by TLC). The mixture was then
concentrated under vacuum, diluted with water, extracted with
CH2Cl2, then dried over MgSO4. Purification by MPLC on
Woelm 32-63 silica gel eluted with 3:7 v/v AcOEt-hexane gave
a 20:47 molar ratio isomeric mixture of 17 (150 mg, 68%).
Recrystallization of the isomeric mixture of 17 from AcOEt
and hexane gave colorless plates with no change in molar ratio
of the isomers.
5-tert-Butyl-7-methoxy-3H-azepin-2-yl 4-tert-butyl-7-
methoxy-2H-azepin-2-yl ether (17): colorless plates; mp
140.5-141.0 °C. Major isomer: 1H NMR (600 MHz, CDCl3) δ
1.09 (9H, s), 1.11 (9H, s), 2.71 (1H, dd, J ) 12.1, 5.6 Hz), 3.14
(1H, dd, J ) 12.1, 7.6 Hz), 3.53 (3H, s), 3.72 (3H, s), 5.40 (1H,
dd, J ) 7.6, 5.6 Hz), 5.47 (1H, s), 5.59 (1H, d, J ) 4.4 Hz),
5.88 (1H, d, J ) 4.4 Hz), 6.35 (1H, d, J ) 12.0 Hz), 6.90 (1H,
d, J ) 12.0 Hz); 13C NMR (50 MHz, CDCl3) δ 29.6 (q), 29.6 (q),
34.4 (s), 34.7 (s), 37.4 (t), 53.3 (q), 55.8 (q), 67.8 (d), 94.0 (d),
112.9 (d), 123.8 (d), 131.2 (d), 139.1 (d), 144.7 (s), 147.4 (s),
154.2 (s), 159.4 (s), 169.1 (s). Minor isomer: 1H NMR (600
MHz, CDCl3) δ 1.06 (9H, s), 1.11 (9H, s), 2.79 (1H, dd, J )
11.7, 4.9 Hz), 3.19 (1H, dd, J ) 11.7, 7.8 Hz), 3.68 (3H, s),
3.77 (3H, s), 5.44 (1H, dd, J ) 7.8, 4.9 Hz), 5.58 (2H, s), 5.61
(1H, s), 6.47 (1H, d, J ) 12.0 Hz), 6.86 (1H, d, J ) 12.0 Hz);
13C NMR (50 MHz, CDCl3) δ 29.5 (q), 29.6 (q), 34.4 (s), 34.7
(s), 37.4 (t), 53.9 (q), 56.4 (q), 66.5 (d), 95.9 (d), 114.2 (d), 124.7
(d), 125.3 (d), 138.5 (d), 146.4 (s), 146.9 (s), 152.7 (s), 160.0 (s),
170.4 (s). IR (KBr) νmax 1673, 1642, 1462, 1439, 1412, 1367,
1255, 1220, 1151 cm-1; UV-vis (EtOH) λmax 247 nm (log ꢀ
4.00); MS (FAB) m/z 373 (M + H)+. Anal. Calcd for C22H32N2O3:
C, 70.94; H, 8.66; N, 7.52. Found: C, 71.08; H, 8.76; N, 7.70.
5-tert-Butyl-3H-azepin-2-yl 4-tert-butyl-7-methoxy-2H-
1
azepin-2-yl ether (13): colorless plates; mp 115-116 °C; H
NMR (600 MHz, CDCl3) δ 1.04 (9H, s), 1.13 (9H, s), 2.62 (1H,
dd, J ) 12.2, 6.1 Hz), 3.16 (1H, dd, J ) 12.2, 7.9 Hz), 3.67
(3H, s), 5.29 (1H, d, J ) 4.9 Hz), 5.53 (1H, dd, J ) 7.9, 6.1
Hz), 5.73 (1H, d, J ) 4.9 Hz), 6.23 (1H, d, J ) 9.3 Hz), 6.48
(1H, d, J ) 12.0 Hz), 6.93 (1H, d, J ) 12.0 Hz), 7.03 (1H, d, J
) 9.3 Hz); 13C NMR (150 MHz, CDCl3) δ 29.3 (q), 29.6 (q), 34.4
(s), 34.6 (s), 37.5 (t), 53.6 (q), 65.4 (d), 115.4 (d), 117.4 (d), 124.8
(d), 127.1 (d), 127.8 (d), 139.0 (d), 146.7 (s), 147.8 (s), 160.3
(s), 168.3 (s); IR (KBr) νmax 1678, 1630, 1446, 1394, 1367, 1267,
1241, 1216, 1181 cm-1; UV-vis (EtOH) λmax 252 nm (log ꢀ
3.90); MS (FAB) m/z 343 (M + H)+. Anal. Calcd for C21H30N2O2:
C, 73.65; H, 8.83; N, 8.18. Found: C, 73.82; H, 8.97; N, 8.47.
Reaction of 13 with NBS. NBS (110 mg, 0.62 mmol) was
dropped into a solution of 13 (200 mg, 0.58 mmol) in CH2Cl2
(5 mL) stirred under a nitrogen atmosphere at 0 °C then the
solution was stirred for 2 h. Separation of the reaction mixture
by MPLC on Woelm 32-63 silica gel at 0 °C eluted with 1:1
v/v AcOEt-hexane gave 10 (1.8 mg, 0.7%), cis-12 (203 mg,
67%), and trans-12 (63 mg, 21%).
Elimination of HBr from 12. A solution of isomeric 12
(280 mg, 0.538 mmol) and DBU (1.00 g, 6.57 mmol) in CH2Cl2
was stirred at room temperature for 2.5 days (reaction progress
monitored by TLC). Volatile components were removed under
vacuum, and isolation by column chromatography on silica gel
eluted with 1:4 v/v AcOEt-hexane gave 11 (220 mg, 93%).
Recrystallization from hexane gave 11 as colorless plates.
Reaction of 13 with NBS in the Presence of Methanol.
NBS (140 mg, 0.79 mmol) was dropped into a solution of 13
(250 mg, 0.73 mmol) and methanol (1 mL, 24.7 mmol) in CH2-
Cl2 (5 mL) stirred under a nitrogen atmosphere at 0 °C then
the solution was stirred for 2 h before treatment with aq K2-
CO3. The organic phase was separated and dried over MgSO4.
Removal of volatile components gave an isomeric mixture of
16 (330 mg, 100%) with a 4:1 molar ratio as a colorless solid.
5-Bromo-4-tert-butyl-5,6-dihydro-2-methoxy-2H-azepin-
7-yl 4-tert-butyl-7-methoxy-2H-azepin-2-yl ether (16):
colorless solid; mp 75-78 °C. Major isomer: 1H NMR (600
MHz, CDCl3) δ 1.09 (9H, s), 1.27 (9H, s), 2.85 (1H, dd, J )
13.9, 6.8 Hz), 3.50 (3H, s), 3.64 (3H, s), 3.95 (1H, dd, J ) 13.9,
1.5 Hz), 4.83 (1H, d, J ) 6.8, 1.5 Hz), 5.40 (1H, d, J ) 4.9 Hz),
5.65 (1H, d, J ) 7.1 Hz), 5.74 (1H, d, J ) 4.9 Hz), 6.10 (1H, d,
J ) 7.1 Hz), 6.47 (1H, d, J ) 12.0 Hz), 6.92 (1H, d, J ) 12.0
Hz); 13C NMR (150 MHz, CDCl3) δ 29.4 (q), 30.9 (q), 34.6 (s),
36.4 (s), 42.3 (d), 44.2 (t), 53.8 (q), 56.1 (q), 66.2 (d), 80.4 (d),
124.5 (d), 124.8 (d), 128.5 (d), 139.1 (d), 146.5 (s), 152.9 (s),
160.3 (s), 171.4 (s). Minor isomer: 1H NMR (600 MHz, CDCl3)
δ 1.04 (9H, s), 1.25 (9H, s), 2.89 (1H, dd, J ) 13.9, 6.8 Hz),
3.46 (3H, s), 3.61 (3H, s), 3.81 (1H, dd, J ) 13.9, 1.5 Hz), 4.79
(1H, d, J ) 6.8, 1.5 Hz), 5.38 (1H, d, J ) 4.9 Hz), 5.59 (1H, d,
J ) 7.1 Hz), 5.83 (1H, d, J ) 4.9 Hz), 6.06 (1H, d, J ) 7.1 Hz),
6.44 (1H, d, J ) 12.0 Hz), 6.92 (1H, d, J ) 12.0 Hz); 13C NMR
(150 MHz, CDCl3) δ 29.5 (q), 30.8 (q), 34.6 (s), 36.5 (s), 41.8
(d), 44.8 (t), 53.4 (q), 56.0 (q), 67.7 (d), 82.7 (d), 124.4 (d), 124.7
Qualitative Nucleophilic Substitution of 7a, 7b, and
8. To a CDCl3 solution of 7a, 7b, or 8 (10 mg) in an NMR
sample tube, a nucleophile was introduced in molar excess.
1
The mixture was periodically observed by H NMR spectros-
copy until no further change in the spectra could be detected.
The results are displayed in Table 6. The products were
purified by MPLC on silica gel at 0 °C.
4-tert-Butyl-7-methoxy-2-propylthio-2H-azepine (9b):
colorless liquid; 1H NMR (200 MHz, CDCl3) δ 1.00 (3H, t, J )
7.4 Hz), 1.09 (9H, s), 1.66 (2H, hext, J ) 7.4 Hz), 2.54-2.83
(2H, m), 3.70 (3H, s), 4.35 (1H, d, J ) 5.8 Hz), 5.66 (1H, d, J
) 5.8 Hz), 6.46 (1H, d, J ) 12.0 Hz), 6.93 (1H, d, J ) 12.0 Hz);
13C NMR (50 MHz, CDCl3) δ 13.6 (q), 23.0 (t), 29.4 (q), 32.3
(t), 34.6 (s), 53.6 (q), 60.2 (d), 124.6 (d), 127.0 (d), 138.9 (d),
147.5 (s), 161.4 (s); IR (film) νmax 1628, 1444, 1243, 1203 cm-1
;
UV-vis (EtOH) λmax 277 nm (log ꢀ 3.36); MS (FAB) m/z 254
(M + H)+; HRMS (FAB) m/z calcd for C14H23NOS (M)+
253.1500, found 253.1464. Anal. Calcd for C14H23NOS: C,
66.36; H, 9.15; N, 5.53. Found: C, 66.17; H, 9.24; N, 5.73.
4-tert-Butyl-7-methoxy-2-propylamino-2H-azepine
(18): colorless solid; mp 75.5-77.0 °C; 1H NMR (600 MHz,
CDCl3) δ 0.95 (3H, t, J ) 7.2 Hz), 1.07 (9H, s), 1.50-1.60 (2H,
m), 1.70 (1H, br s), 2.51-2.57 (1H, m), 2.93-2.99 (1H, m), 3.66
(3H, s), 3.75 (1H, d, J ) 4.8 Hz), 5.62 (1H, d, J ) 4.8 Hz), 6.46
(1H, d, J ) 12.0 Hz), 6.92 (1H, d, J ) 12.0 Hz); 13C NMR (150
MHz, CDCl3) δ 12.0 (q), 23.4 (t), 29.6 (q), 34.5 (s), 48.0 (t), 53.4
(q), 70.3 (d), 124.5 (d), 128.9 (d), 139.0 (d), 145.8 (s), 159.5 (s);
IR (KBr) νmax 3260, 1624, 1441, 1241 cm-1; UV-vis (EtOH)
λmax 276 nm (log ꢀ 3.07); MS (FAB) m/z 237 (M + H)+; HRMS
(FAB) m/z calcd for C14H25N2O (M + H)+ 237.1967, found
237.1989.
J. Org. Chem, Vol. 70, No. 9, 2005 3435